VDAC2-NEO1 Fusion FISH Probe
The VDAC2-NEO1 Fusion FISH Probe is used to confirm a fusion of the VDAC2 and NEO1 genes. The fusion of the VDAC2 and NEO1 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| VDAC2-NEO1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| VDAC2-NEO1-20-AQAQ | 20 (40 μL) | 200 μL |
|
NEO1 Gene Summary
This gene encodes a cell surface protein that is a member of the immunoglobulin superfamily. The encoded protein consists of four N-terminal immunoglobulin-like domains, six fibronectin type III domains, a transmembrane domain and a C-terminal internal domain that shares homology with the tumor suppressor candidate gene DCC. This protein may be involved in cell growth and differentiation and in cell-cell adhesion. Defects in this gene are associated with cell proliferation in certain cancers. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Gene Name: Neogenin 1
Chromosome: CHR15: 73344824 -73597547
Locus: 15q24.1
VDAC2 Gene Summary
This gene encodes a member of the voltage-dependent anion channel pore-forming family of proteins that are considered the main pathway for metabolite diffusion across the mitochondrial outer membrane. The encoded protein is also thought to be involved in the mitochondrial apoptotic pathway via regulation of BCL2-antagonist/killer 1 protein activity. Pseudogenes have been identified on chromosomes 1, 2, 12 and 21, and alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Gene Name: Voltage Dependent Anion Channel 2
Chromosome: CHR10: 76969911 -76991207
Locus: 10q22.2
Gene Diseases
The VDAC2 NEO1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|